Hans Wolf

5.2k total citations
130 papers, 4.0k citations indexed

About

Hans Wolf is a scholar working on Surgery, Molecular Biology and Urology. According to data from OpenAlex, Hans Wolf has authored 130 papers receiving a total of 4.0k indexed citations (citations by other indexed papers that have themselves been cited), including 56 papers in Surgery, 40 papers in Molecular Biology and 23 papers in Urology. Recurrent topics in Hans Wolf's work include Bladder and Urothelial Cancer Treatments (50 papers), Urinary and Genital Oncology Studies (20 papers) and Urological Disorders and Treatments (13 papers). Hans Wolf is often cited by papers focused on Bladder and Urothelial Cancer Treatments (50 papers), Urinary and Genital Oncology Studies (20 papers) and Urological Disorders and Treatments (13 papers). Hans Wolf collaborates with scholars based in Denmark, United States and United Kingdom. Hans Wolf's co-authors include Torben F. Ørntoft, Julio E. Celis, Knud Højgaard, Thomas Thykjær, Hanne H. Rasmussen, Morten Østergaard, Mogens Kruhøffer, Jens Ledet Jensen, Stephen Hamilton‐Dutoit and Lars Dyrskjøt and has published in prestigious journals such as The Lancet, Journal of Biological Chemistry and Nature Genetics.

In The Last Decade

Hans Wolf

128 papers receiving 3.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hans Wolf Denmark 35 1.9k 1.4k 608 563 535 130 4.0k
Yinghao Sun China 40 2.5k 1.3× 728 0.5× 580 1.0× 1.4k 2.5× 1.8k 3.3× 167 4.7k
Tomoaki Fujioka Japan 35 1.8k 0.9× 679 0.5× 774 1.3× 874 1.6× 619 1.2× 173 3.8k
Yasuyoshi Miyata Japan 33 1.5k 0.8× 542 0.4× 641 1.1× 570 1.0× 608 1.1× 174 3.3k
Chuanliang Xu China 31 987 0.5× 681 0.5× 266 0.4× 750 1.3× 353 0.7× 114 2.3k
Roman A. Blaheta Germany 39 2.5k 1.3× 797 0.6× 1.0k 1.7× 663 1.2× 581 1.1× 208 5.1k
Richard Y. Ball United Kingdom 25 1.0k 0.5× 747 0.5× 424 0.7× 582 1.0× 440 0.8× 74 2.8k
Anita L. Sabichi United States 35 1.5k 0.8× 803 0.6× 1.2k 1.9× 1.1k 2.0× 574 1.1× 90 4.4k
Roberto Barrios United States 36 1.6k 0.9× 485 0.3× 712 1.2× 1.8k 3.1× 580 1.1× 110 4.2k
Sheng Tai China 29 1.7k 0.9× 459 0.3× 478 0.8× 528 0.9× 1.0k 1.9× 110 3.6k
Irma Virant‐Klun Slovenia 34 1.6k 0.9× 434 0.3× 760 1.3× 410 0.7× 476 0.9× 111 4.4k

Countries citing papers authored by Hans Wolf

Since Specialization
Citations

This map shows the geographic impact of Hans Wolf's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hans Wolf with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hans Wolf more than expected).

Fields of papers citing papers by Hans Wolf

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hans Wolf. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hans Wolf. The network helps show where Hans Wolf may publish in the future.

Co-authorship network of co-authors of Hans Wolf

This figure shows the co-authorship network connecting the top 25 collaborators of Hans Wolf. A scholar is included among the top collaborators of Hans Wolf based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hans Wolf. Hans Wolf is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Celis, Julio E., Pamela Celis, Hildur Pálsdóttir, et al.. (2002). Proteomic Strategies to Reveal Tumor Heterogeneity among Urothelial Papillomas. Molecular & Cellular Proteomics. 1(4). 269–279. 48 indexed citations
2.
Sørensen, Boe Sandahl, et al.. (2001). A subclass of HER1 ligands are prognostic markers for survival in bladder cancer patients.. PubMed. 61(16). 6227–33. 99 indexed citations
3.
Wolf, Hans, et al.. (2001). Prognostic Value of p53, p21/WAF1, Bcl-2, Bax, Bak and Ki-67 Immunoreactivity in pT1 G3 Urothelial Bladder Carcinomas. Tumor Biology. 22(5). 328–336. 37 indexed citations
4.
5.
Christensen, Mariann, Hans Wolf, & Torben F. Ørntoft. (2000). Microsatellite alterations in urinary sediments from patients with cystitis and bladder cancer. International Journal of Cancer. 85(5). 614–617. 33 indexed citations
6.
Celis, Julio E., Hans Wolf, & Morten Østergaard. (2000). Bladder squamous cell carcinoma biomarkers derived from proteomics. Electrophoresis. 21(11). 2115–2121. 87 indexed citations
7.
Zieger, Karsten, et al.. (2000). Long‐term follow‐up of noninvasive bladder tumours(stage Ta): recurrence and progression. British Journal of Urology. 85(7). 824–828. 70 indexed citations
8.
Celis, Julio E., Morten Østergaard, Hanne H. Rasmussen, et al.. (1999). A comprehensive protein ressource for the study of bladder cancer: http://biobase.dk/cgi-bin/celis. Electrophoresis. 20(2). 300–309. 51 indexed citations
9.
Christensen, Mariann, et al.. (1998). Pronounced microsatellite instability in transitional cell carcinomas from young patients with bladder cancer. International Journal of Cancer. 79(4). 396–401. 42 indexed citations
10.
Ørntoft, Torben F., Else Marie Vestergaard, Eric H. Holmes, et al.. (1996). Influence of Lewis α1-3/4-L-Fucosyltransferase (FUT3) Gene Mutations on Enzyme Activity, Erythrocyte Phenotyping, and Circulating Tumor Marker Sialyl-Lewis a Levels. Journal of Biological Chemistry. 271(50). 32260–32268. 102 indexed citations
11.
Fisher, Susan G., Luis Benı́tez-Bribiesca, Ingo Nindl, et al.. (1996). The Association of Human Papillomavirus Type 16 E6 and E7 Antibodies with Stage of Cervical Cancer. Gynecologic Oncology. 61(1). 73–78. 31 indexed citations
12.
Deckert, Jürgen, Markus M. Nöthen, Stephen P. Bryant, et al.. (1995). Human Adenosine A1 Receptor Gene: Systematic Screening for DNA Sequence Variation and Linkage Mapping on Chromosome 1q31-32.1 Using a Silent Polymorphism in the Coding Region. Biochemical and Biophysical Research Communications. 214(2). 614–621. 5 indexed citations
13.
Andersen, Jay, Peter Ekman, Hans Wolf, et al.. (1995). Can finasteride reverse the progress of benign prostatic hyperplasia? a two-year placebo-controlled study. Urology. 46(5). 631–637. 121 indexed citations
14.
Vindeløv, Lars L., Ib Jarle Christensen, Svend A. Engelholm, et al.. (1995). Prognostic significance of dna content in bladder cancer based on flow cytometric analysis of 249 transitional cell carcinomas. Cytometry. 22(2). 93–102. 12 indexed citations
15.
Wolf, Hans, et al.. (1991). Frequency and mechanism of Lewis antigen expression in human urinary bladder and colon carcinoma patients. British Journal of Cancer. 63(4). 583–586. 11 indexed citations
16.
Wolf, Hans. (1991). Prognostic Factors in Bladder Carcinoma. Scandinavian Journal of Urology and Nephrology. 25(sup138). 153–160. 10 indexed citations
17.
Langkilde, Niels Christian, et al.. (1989). Binding of wheat and peanut lectins to human transitional cell carcinomas. Correlation with histopathologic grade, invasion, and dna ploidy. Cancer. 64(4). 849–853. 14 indexed citations
18.
Lower, Gerald M., et al.. (1979). N-Acetyltransferase phenotype and risk in urinary bladder cancer: approaches in molecular epidemiology. Preliminary results in Sweden and Denmark. Environmental Health Perspectives. 29. 71–79. 152 indexed citations
19.
Wolf, Hans. (1971). Hormonal alteration of efficiency of conversion of tryptophan to urinary metabolites of niacin in man. American Journal of Clinical Nutrition. 24(7). 792–799. 11 indexed citations
20.
Müller, Ulrich, et al.. (1959). Vitamin B6. 3. Vitamin B6 in fresh and preserved milk.. Milk science international/Milchwissenschaft. 14. 115–119. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yinghao Sun Breakdown of academic impact, for papers by Tomoaki Fujioka Breakdown of academic impact, for papers by Yasuyoshi Miyata Breakdown of academic impact, for papers by Chuanliang Xu Breakdown of academic impact, for papers by Roman A. Blaheta Breakdown of academic impact, for papers by Richard Y. Ball Breakdown of academic impact, for papers by Anita L. Sabichi Breakdown of academic impact, for papers by Roberto Barrios Breakdown of academic impact, for papers by Sheng Tai Breakdown of academic impact, for papers by Irma Virant‐Klun
Rankless by CCL
2026